Wells Fargo Downgrades Inari Medical to Equal-Weight, Raises Price Target to $80
Wells Fargo Downgrades Inari Medical to Equal-Weight, Raises Price Target to $80
富國銀行將Inari Medical評級下調至持平,並將目標價上調至80美元
Wells Fargo analyst Larry Biegelsen downgrades Inari Medical (NASDAQ:NARI) from Overweight to Equal-Weight and raises the price target from $65 to $80.
富國銀行分析師拉里·比根森將Inari Medical(納斯達克:NARI)評級從超配下調至平配,並將目標價格從65美元上調至80美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。